Black Diamond Therapeutics, Inc. (BDTX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 122.97M | 132.44M | 138.99M | 146.73M | 155.68M | 101.18M | 115.54M | 126.75M | 118.81M | 134.03M | 147.05M | 92.99M |
| Cash & Short-Term Investments | 118.26M | 128.65M | 135.5M | 142.83M | 152.4M | 98.58M | 112.68M | 122.97M | 115.2M | 131.4M | 144.26M | 89.53M |
| Cash Only | 30.07M | 20.99M | 30.86M | 29.99M | 98.42M | 36.44M | 23.43M | 32.81M | 25.42M | 56.22M | 57.98M | 41.89M |
| Short-Term Investments | 88.19M | 107.66M | 104.64M | 112.84M | 53.98M | 62.14M | 89.26M | 90.16M | 89.78M | 75.18M | 86.28M | 47.64M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.71M | 3.79M | 0 | 3.9M | 3.28M | 2.6M | 2.86M | 3.78M | 3.61M | 2.63M | 2.79M | 3.46M |
| Total Non-Current Assets | 9.96M | 10.57M | 18.74M | 19.66M | 20.57M | 21.46M | 22.36M | 23.23M | 23.71M | 24.53M | 25.33M | 26.89M |
| Property, Plant & Equipment | 9.1M | 9.67M | 17.8M | 18.67M | 19.54M | 20.4M | 21.24M | 22.07M | 22.9M | 23.71M | 24.51M | 25.66M |
| Fixed Asset Turnover | - | - | - | - | 3.51x | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 831K | 829K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 29K | 73K | 944K | 985K | 1.03M | 1.07M | 1.12M | 1.16M | 819K | 823K | 819K | 1.23M |
| Total Assets | 132.92M | 143.01M | 157.73M | 166.38M | 176.25M | 122.64M | 137.9M | 149.99M | 142.52M | 158.57M | 172.38M | 119.88M |
| Asset Turnover | - | - | - | - | 0.47x | - | - | - | - | - | - | - |
| Asset Growth % | -24.58% | 16.61% | 14.39% | 10.93% | 23.66% | -22.66% | -20.01% | 25.11% | 5.12% | 1.48% | -4.45% | -39.71% |
| Total Current Liabilities | 14.53M | 15.73M | 15.54M | 16.8M | 16.85M | 20.57M | 20.8M | 18.44M | 16.85M | 19.65M | 15.07M | 13.9M |
| Accounts Payable | 2.97M | 579K | 975K | 771K | 2.63M | 4.01M | 1.97M | 763K | 1.18M | 2.32M | 694K | 2.74M |
| Days Payables Outstanding | 5.91K | - | - | 1.8K | - | - | - | 1.03K | 1.85K | - | - | - |
| Short-Term Debt | 3.79M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 7.77M | 15.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 8.46x | 8.42x | 8.94x | 8.73x | 9.24x | 4.92x | 5.55x | 6.87x | 7.05x | 6.82x | 9.76x | 6.69x |
| Quick Ratio | 8.46x | 8.42x | 8.94x | 8.73x | 9.24x | 4.92x | 5.55x | 6.87x | 7.05x | 6.82x | 9.76x | 6.69x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 14.09M | 15.07M | 16.04M | 16.97M | 17.88M | 18.78M | 19.67M | 20.53M | 21.36M | 22.18M | 23M | 23.78M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 14.09M | 15.07M | 16.04M | 16.97M | 17.88M | 18.78M | 19.67M | 20.53M | 21.36M | 22.18M | 23M | 23.78M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 28.62M | 30.8M | 31.58M | 33.77M | 34.73M | 39.35M | 40.47M | 38.97M | 38.22M | 41.83M | 38.06M | 37.68M |
| Total Debt | 17.88M | 15.07M | 16.04M | 20.75M | 21.59M | 22.19M | 23M | 23.78M | 24.55M | 25.3M | 26.04M | 26.76M |
| Net Debt | -12.19M | -5.92M | -14.83M | -9.24M | -76.84M | -14.25M | -426K | -9.03M | -877K | -30.92M | -31.94M | -15.13M |
| Debt / Equity | 0.17x | 0.13x | 0.13x | 0.16x | 0.15x | 0.27x | 0.24x | 0.21x | 0.24x | 0.22x | 0.19x | 0.33x |
| Debt / EBITDA | - | - | - | - | 0.40x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | -1.41x | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 104.3M | 112.21M | 126.15M | 132.61M | 141.52M | 83.28M | 97.43M | 111.02M | 104.31M | 116.74M | 134.32M | 82.2M |
| Equity Growth % | -26.3% | 34.73% | 29.48% | 19.45% | 35.67% | -28.66% | -27.47% | 35.06% | 6.23% | 0.9% | 0.82% | -46.05% |
| Book Value per Share | 1.82 | 1.97 | 2.22 | 2.33 | 2.45 | 1.47 | 1.72 | 2.01 | 2.01 | 2.46 | 2.64 | 2.25 |
| Total Shareholders' Equity | 104.3M | 112.21M | 126.15M | 132.61M | 141.52M | 83.28M | 97.43M | 111.02M | 104.31M | 116.74M | 134.32M | 82.2M |
| Common Stock | 8K | 8K | 8K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 7K | 5K |
| Retained Earnings | -473.78M | -464.74M | -449.62M | -441.13M | -430.56M | -487.11M | -471.12M | -455.56M | -435.66M | -417.43M | -398.02M | -375.02M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -36K | 101K | 142K | -25K | -19K | 24K | 107K | -115K | -95K | -27K | -364K | -661K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |